US Stock MarketDetailed Quotes

RCOR.WS RENOVACOR INC C/WTS (TO SUB FOR ORD)

Watchlist
  • 0.0710
  • 0.00000.00%
Close Nov 30 16:00 ET
0Market Cap0.00P/E (TTM)

About RENOVACOR INC C/WTS (TO SUB FOR ORD) Company

Renovacor Inc is a preclinical stage gene therapy company developing a pipeline of innovative and proprietary AAV-based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Its therapeutic focus is on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.

Company Profile

SymbolRCOR.WS
Company NameRENOVACOR INC C/WTS (TO SUB FOR ORD)
CEOMs. Magdalene Cook
MarketAMEX
Employees19
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Websitehttps://www.renovacor.com

Company Executives

  • Name
  • Position
  • Salary
  • Magdalene Cook
  • Chairman of the Board, President and Chief Executive Officer
  • 2.11M
  • Matthew Killeen
  • Chief Scientific Officer
  • 1.41M
  • Wendy F. DiCicco
  • Chief Financial Officer
  • --
  • Marc Semigran
  • Chief Medical Officer
  • 2.27M
  • Joseph Carroll
  • Chief Accounting Officer and Corporate Secretary
  • --
  • Thomas E. Needham, Jr
  • Independent Director
  • 139.96K
  • Jonas Grossman
  • Independent Director
  • 142.76K
  • Dr. Joan Lau
  • Independent Director
  • 138.32K
  • Dr. Edward J. Benz, Jr,M.D.
  • Independent Director
  • 162.31K
  • Gregory F. Covino
  • Independent Director
  • 143.58K
  • Dr. Gbola Amusa, M.D.
  • Independent Director
  • 139.47K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg